NanoString Technologies - Stock Split History | NSTG

Stock split history for NanoString Technologies since 2020. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
NanoString Technologies Annual Stock Splits
NanoString Technologies Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.921B $0.126B
NanoString Technologies, Inc. is engaged in the development, manufacture and sale of life science tools. It provides nCounter Analysis System which supports research and development of clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform. The company also offers nSolver Analysis software, gene expression panels, miRNA expression assay kits, cancer copy number variation panels, nCounter leukemia fusion gene expression assay kits and human karyotype panels, custom CodeSets and master kits that are ancillary reagents, cartridges, tips and reagent plates to setup and process samples in its instruments. It markets its systems and related consumables to researchers in academic, government and biopharmaceutical laboratories primarily in North America, Europe, the Middle East and the Asia Pacific. NanoString Technologies, Inc. is headquartered in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $145.889B 25.53
Medtronic (MDT) Ireland $126.096B 16.95
Stryker (SYK) United States $62.094B 20.06
Boston Scientific (BSX) United States $45.907B 20.68
Baxter (BAX) United States $43.082B 26.29
Coloplast (CLPBY) Denmark $31.666B 48.87
Lonza Group Ag (LZAGY) Switzerland $30.808B 0.00
Terumo (TRUMY) Japan $25.125B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $24.988B 0.00
ResMed (RMD) United States $22.893B 39.77
Zimmer Biomet Holdings (ZBH) United States $20.215B 12.44
Smith & Nephew SNATS (SNN) United Kingdom $15.935B 0.00
Sunny Optical Technology (SNPTF) China $14.665B 0.00
Bio-Rad Laboratories (BIO) United States $11.410B 53.33
Insulet (PODD) United States $10.806B 661.15
William Demant Holdings (WILYY) Denmark $7.898B 0.00
Hill-Rom Holdings (HRC) United States $7.302B 21.00
DiaSorin S.p.A (DSRLF) Italy $6.994B 0.00
Perrigo (PRGO) Ireland $6.476B 11.80
GN STORE NORD (GNNDY) Denmark $6.057B 31.29
Haemonetics (HAE) United States $5.142B 31.65
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Canopy Growth (CGC) Canada $5.010B 0.00
ICU Medical (ICUI) United States $4.301B 28.09
Quidel (QDEL) United States $4.034B 35.41
Neogen (NEOG) United States $3.598B 60.95
Agios Pharmaceuticals (AGIO) United States $2.706B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $2.677B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.438B 0.00
NuVasive (NUVA) United States $2.419B 18.71
Envista Holdings (NVST) United States $2.275B 0.00
National Vision Holdings (EYE) United States $1.476B 24.86
AtriCure (ATRC) United States $1.368B 0.00
Cardiovascular Systems (CSII) United States $1.302B 0.00
TG Therapeutics (TGTX) United States $1.046B 0.00
Phibro Animal Health (PAHC) United States $0.986B 19.50
Aurora Cannabis (ACB) Canada $0.973B 0.00
VAREX IMAGING (VREX) United States $0.835B 17.34
Aphria (APHA) $0.802B 0.00
Cerus (CERS) United States $0.788B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.757B 136.15
Omeros (OMER) United States $0.752B 0.00
InMode (INMD) Israel $0.709B 0.00
OraSure Technologies (OSUR) United States $0.689B 85.46
PetIQ (PETQ) United States $0.675B 18.38
Eagle Pharmaceuticals (EGRX) United States $0.647B 38.48
Quanterix (QTRX) United States $0.596B 0.00
LeMaitre Vascular (LMAT) United States $0.490B 27.59
Surmodics (SRDX) United States $0.455B 52.30
Lantheus Holdings (LNTH) United States $0.440B 9.90
Owens & Minor (OMI) United States $0.427B 11.67
Meridian Bioscience (VIVO) United States $0.380B 15.31
Zynex (ZYXI) United States $0.371B 39.96
Vapotherm (VAPO) United States $0.367B 0.00
Repro-Med Systems (KRMD) United States $0.337B 212.50
Utah Medical Products (UTMD) United States $0.305B 21.83
Organigram Holdings (OGI) Canada $0.296B 0.00
MacroGenics (MGNX) United States $0.273B 0.00
Cytosorbents (CTSO) United States $0.220B 0.00
BioLife Solutions (BLFS) United States $0.210B 128.63
Female Health (VERU) United States $0.203B 0.00
HEXO (HEXO) $0.197B 0.00
InfuSystems Holdings (INFU) United States $0.191B 159.67
Exagen (XGN) United States $0.170B 0.00
Viemed Healthcare (VMD) United States $0.169B 19.13
Rockwell Medical (RMTI) United States $0.144B 0.00
United Health Products (UEEC) United States $0.140B 0.00
Evolus (EOLS) United States $0.131B 0.00
Bovie Medical (APYX) United States $0.127B 0.00
Liberty Health Sciences (LHSIF) Canada $0.111B 0.00
Chembio Diagnostics (CEMI) United States $0.110B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.107B 0.00
Fonar (FONR) United States $0.097B 7.08
Chimerix (CMRX) United States $0.086B 0.00
Brainsway (BWAY) Israel $0.082B 0.00
MTech Acquisition (KERN) United States $0.079B 0.00
United-Guardian (UG) United States $0.063B 13.17
Green Organic Dutchman Holdings (TGODF) Canada $0.062B 0.00
Nephros (NEPH) United States $0.060B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
Wound Management Technologies (SMTI) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.049B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
ImmuCell (ICCC) United States $0.029B 0.00
FSD PHARMA INC (HUGE) Canada $0.026B 0.00
NF Energy Saving (BIMI) China $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00